FDA Approves Botulism Countermeasure
CDC began developing Botulism Antitoxin Heptavalent about 10 years ago, and it became one of the first medical countermeasures approved for advanced development and procurement under Project BioShield, in 2006.
Article by [author-name] (c) OH&S News
- Read full story here.
No comments:
Post a Comment